Press release
http://www.openpr.com/news/archive/138126/iHealthcareAnalyst-Inc.html
According to a market research report published by iHealthcareAnalyst, Inc., Preimplantation Genetic Diagnosis Testing Market – Global Diagnostic Applications and End Users Analysis and Forecast 2013-2020, the global Preimplantation genetic diagnosis testing market was valued at USD 78 Million in 2015 and is estimated to reach USD 116 Million by 2020, at a CAGR of 8.3% from 2016 to 2020.Browse the Preimplantation Genetic Diagnosis Testing Market – Global Diagnostic Applications and End Users Analysis and Forecast 2013-2020 at http://www.ihealthcareanalyst.com/report/preimplantation-genetic-diagnosis-market/
Preimplantation genetic diagnosis (PGD or PIGD) is used to identify genetic defects in embryos created through in vitro fertilization (IVF) before pregnancy and can test for more than 100 different genetic conditions. PGD is available for a large number of monogenic disorders such as single gene disorders (autosomal recessive, autosomal dominant or X-linked) or chromosomal structural aberrations (such as a balanced translocation). The Preimplantation genetic diagnosis testing market report estimates the market size (Revenue USD million - 2013 to 2020) for market segmentation based on diagnostic test type (aneuploidy screening, chromosomal aberrations, gender selection, HLA typing, single gene disorders, X-linked diseases, etc.), and forecasts growth trends (CAGR% - 2016 to 2020). It also provides the detailed market landscape and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments.
The global Preimplantation genetic diagnosis testing market is segmented as:
1. Diagnostic Test Type
1.1. Aneuploidy Screening
1.2. Chromosomal Aberrations
1.3. Gender Selection
1.4. Human Leukocyte Antigen (HLA) Typing
1.5. Single Gene Disorder
1.6. X-linked Diseases
2. End User
2.1. Hospitals
2.2. PGD Centers
2.3. Diagnostic Laboratories
2.4. Others
3. Geography (Region, Country)
3.1. North America (U.S., Canada)
3.2. Latin America (Brazil, Mexico, Rest of LA)
3.3. Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
3.4. Asia Pacific (Japan, China, India, Rest of APAC)
3.5. Rest of the World
4. Company Profiles
4.1. Genea Ltd.
4.2. Genesis Genetics
4.3. Illumina, Inc.
4.4. Laboratory Corporation of America Holdings (LabCorp)
4.5. Natera, Inc.
4.6. PerkinElmer, Inc.
4.7. Quest Diagnostics, Inc.
4.8. Reproductive Genetics Institute
4.9. Reprogenetics LLC
iHealthcareAnalyst, Inc. is a global health care market research and consulting company providing market analysis, and competitive intelligence services to global clients. The Company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals.
iHealthcareAnalyst, Inc. provides industry participants and stakeholders with strategically analyzed, unbiased view of market dynamics and business opportunities within its coverage areas.
Ana Aitawa
iHealthcareAnalyst, Inc.
2109, Mckelvey Hill Drive,
Maryland Heights, MO 63043
United States
Phone: (314) 736-9294.
Email: sales@ihealthcareanalyst.com
http://www.ihealthcareanalyst.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release http://www.openpr.com/news/archive/138126/iHealthcareAnalyst-Inc.html here
News-ID: 345148 • Views: …
More Releases from iHealthcareAnalyst, Inc.

Global Amyotrophic Lateral Sclerosis Devices Market $19.5 Billion by 2029
The global market for amyotrophic lateral sclerosis devices or motor neuron disease devices anticipated to reach $19.5 billion by 2029, growing at a CAGR of 7.3% over the forecast period, driven by increasing incidence, rising geriatric population, lack of curative treatment, growing public awareness, and technological advancements in palliative care.
https://www.ihealthcareanalyst.com/global-amyotrophic-lateral-sclerosis-devices-market/
Amyotrophic lateral sclerosis or Lou Gehrig's disease or motor neuron disease (MND) is characterized by progressive degeneration of the motor nerve…

Global Blood Gas Monitoring Products Market Growing at CAGR of 6.2% to Reach $5. …
The global market for blood gas monitoring products is estimated to reach $5.5 billion by the end of 2025, expanding at a CAGR of 6.2% during the forecast period, supported by growing geriatric population, rising prevalence of chronic diseases, and technological advances.
The global blood gas monitoring devices market research report provides market size (Revenue US$ Million 2017 to 2025), market share analysis, growth trends and forecast (CAGR%, 2019 to 2025).…

Advances in Mobile Connectivity Services to Drive Telemedicine Technologies and …
According to a new market research report Telemedicine Technologies and Services Market 2015-2023 published by iHealthcareAnalyst, Inc., the global computer-aided detection market to reach US$ 73.2 Billion by 2023, expanding at a CAGR of 13.5% from 2018-2023.
Visit the Global Telemedicine Technologies and Services Market Analysis and Forecast 2018-2023 report at https://www.ihealthcareanalyst.com/report/telemedicine-technologies-services-market/
The global telemedicine technologies and services market newly published (updated 2018) report estimates the market size (US$ million 2015-2023)…

Global Internet Pharmacies Market to Cross US$ 100 Billion by 2023
The global internet pharmacies market is estimated to reach US$ 106 Billion by 2023, growing at a CAGR of 15.7% over the forecast period, driven by rising personal disposable income, lower prices, surge in internet penetration, stupendous growth of online retail market and a large number of online players entering the online healthcare product segment.
The major players are in a race to increase their share in the industry by…
More Releases for Gene
Evolving Market Trends In The CRISPR Gene Editing Industry: Innovative Gene Ther …
The CRISPR Gene Editing Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected CRISPR Gene Editing Market Size During the Forecast Period?
The CRISPR gene editing market has grown exponentially in recent years. It will grow from $2.26 billion in 2024 to $2.88…
Gene Delivery Systems Market
The worldwide Gene Delivery Systems Market is valued at US$ 3 billion right now and is forecasted to hit US$ 4.1 billion by 2027. The overall demand for these systems is expected to grow steadily at a rate of 6.5% each year from 2022 to 2027.
Get Free Sample Research Report:
https://www.factmr.com/connectus/sample?flag=S&rep_id=7721
Specifically, there's a significant increase expected in the demand for viral gene delivery systems, which are anticipated to grow at a…
Gene Therapy in CNS Disorder Market - Gene Therapy's Neurological Revolution: Il …
Newark, New Castle, USA - new report, titled Gene Therapy in CNS Disorder Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Gene Therapy in CNS Disorder market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Gene Therapy in CNS Disorder market.…
Cell and Gene Therapy Market Global Analysis By Type (Cell Therapy, Gene Therapy …
Gene and cell therapy uses genes and cells for the treatment of genetic diseases. Genetic diseases are caused by mutations, or errors in genes which can be passed down from one generation to another. Gene therapy aims to treat diseases by using genetic material, or DNA, to manipulate a patient's cells by replacing, changing or introducing genome into cells- either internally or externally. Cell therapy aims to treat diseases by…
Competitive and Opportunities Analysis of Gene Therapy Market of Gene Therapy Ma …
Global Gene Therapy Market accounted for US$ 2.05 billion in 2020 and is estimated to be US$ 12.29 billion by 2030 and is anticipated to register a CAGR of 19.8%. Gene therapy means fixing a working gene to an individual who features a damaged gene. The European Commission has approved this method for one particular treatment. The treatment by the merchandise Glybera uses an epidemic to infect muscle cells with…
CRISPR and CAS Gene Market Continues to Explore Modify gene function of Genome E …
CRISPR Clinopathomics is an emerging science with applications in biotechnology and cellular biology. It is a genome-wide, single-gene-based technology to which various pharmacological agents can be added to promote disease resistance. It has great potential to address all life sciences challenges with an approach that allows for the production of multiple proteins that can attack many of life's common challenges. This technology can potentially address most life-threatening diseases such as…